Report LibraryAll Reports
Datamonitor Healthcare Oncology: Basal Cell Carcinoma Market Spotlight
Retail Price: $2,995.00*BioMedTracker Subscriber Price: $2,095.00 - click here to log in
August 31, 2018Basal cell carcinoma (BCC), a non-melanoma skin cancer (NMSC), is the most common form of skin cancer, accounting for 75–80% of all skin cancers. BCCs are uncontrolled and abnormal growths that arise in the basal cells of the skin. The tumors primarily affect the photoexposed areas, most commonly in the head, and rarely appear on perigenital and genitalia regions. The disease progression is slow and metastases can be seen in <0.5% of BCC cases, however, it can be locally disfiguring and destructive. BCC is more common in fair-skinned people with a genetic history of the condition, and incidence increases when these individuals are located at higher altitudes or closer to the equator.
This Datamonitor Healthcare report contains a Market Spotlight module.
|Disease Group Covered:||Oncology|